Correlation Between Checkpoint Therapeutics and Seres Therapeutics

Can any of the company-specific risk be diversified away by investing in both Checkpoint Therapeutics and Seres Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Checkpoint Therapeutics and Seres Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Checkpoint Therapeutics and Seres Therapeutics, you can compare the effects of market volatilities on Checkpoint Therapeutics and Seres Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Checkpoint Therapeutics with a short position of Seres Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Checkpoint Therapeutics and Seres Therapeutics.

Diversification Opportunities for Checkpoint Therapeutics and Seres Therapeutics

0.43

Correlation Coefficient

Checkpoint Therapeutics  Seres Therapeutics

Very weak diversification

The 3 months correlation between Checkpoint and Seres is 0.43. Overlapping area represents the amount of risk that can be diversified away by holding Checkpoint Therapeutics and Seres Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Seres Therapeutics and Checkpoint Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Checkpoint Therapeutics are associated (or correlated) with Seres Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Seres Therapeutics has no effect on the direction of Checkpoint Therapeutics i.e., Checkpoint Therapeutics and Seres Therapeutics go up and down completely randomly.

Pair Corralation between Checkpoint Therapeutics and Seres Therapeutics

Given the investment horizon of 90 days Checkpoint Therapeutics is expected to under-perform the Seres Therapeutics. In addition to that, Checkpoint Therapeutics is 1.04 times more volatile than Seres Therapeutics. It trades about -0.13 of its total potential returns per unit of risk. Seres Therapeutics is currently generating about -0.07 per unit of volatility. If you would invest  98.00  in Seres Therapeutics on November 29, 2024 and sell it today you would lose (23.00) from holding Seres Therapeutics or give up 23.47% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Checkpoint Therapeutics  vs.  Seres Therapeutics

Checkpoint Therapeutics

Risk-Adjusted Performance

Very Weak

Over the last 90 days Checkpoint Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in March 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Seres Therapeutics

Risk-Adjusted Performance

Very Weak

Over the last 90 days Seres Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite uncertain performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in March 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Pair Trading with Checkpoint Therapeutics and Seres Therapeutics

The main advantage of trading using opposite Checkpoint Therapeutics and Seres Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Checkpoint Therapeutics position performs unexpectedly, Seres Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Seres Therapeutics will offset losses from the drop in Seres Therapeutics' long position.

The idea behind Checkpoint Therapeutics and Seres Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.